Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease

doi:10.3877/cma.j.issn.2095-655X.2015.04.013

Abstract

Abstract:

Objective

To explore the diagnostic features of 17β-Hydroxysteroid dehydrogenase 10 disease(HSD10 disease).

Methods

The clinical data of a 7-months-old infantile who was diagnosed in the First People′s Hospital of Jining was retrospectively analyzed, and relevant literatures were reviewed.

Results

The boy was mainly presented with neurodegeneration, convulsion, and horizontal nystagmus.The cerebral magnetic resonance imaging and the ambulatory electroencephalogram were negative.The blood acylcarnitine and urinary organic acid analysis were normal.The concentrations of serum myocardial enzymes increased, including glutamic oxalocetic transaminase (79.8U/L), creatine kinase (221U/L), creatine kinase isoenzyme MB (43.5U/L), lactate dehydrogenase (356U/L), hydroxybutyric dehydrogenase (339U/L). The neurological development was moderate mental retardation.The diagnosis was confirmed by molecular genetic study of the gene HSD17B10.The patient was hemizygous for the previously described mutation p. R130C (c.388C>T).

Conclusions

HSD10 disease mainly damages the nervous system.Affected patients show a progressive neurodegenerative disease course.Confirmation of the diagnosis is based on the identification of a disease-causing mutation in the HSD17B10 gene.

Key words: 17β-Hydroxysteroid dehydrogenase 10 disease, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, Diagnosis

Zhiqiang Sheng, Yigang Man. Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease[J]. Chinese Journal of Diagnostics(Electronic Edition), 2015, 03(04): 271-273.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2015.04.013

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2015/V03/I04/271

References 19

[1]	Zschocke, J.HSD10 disease：clinical consequences of mutations in the HSD17B10 gene[J]. J Inherited Metab Dis, 2012, 35(1): 81-89.
[2]	Zschocke J,Ruiter JPN,Brand J, et al.Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deciency：a novel inborn error of branched-chain fatty acid and isoleucine catabolism[J]. Pediatr Res, 2000, 48(6): 852-855.
[3]	Ensenauer R,Niederhoff H,Ruiter JP, et al.Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. Ann Neurol, 2002, 51(5): 656-659.
[4]	Olpin SE,Pollitt RJ,McMenamin J, et al.2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man[J]. J Inherit Metab Dis, 2002, 25(6): 477-482.
[5]	Sutton VR,O’Brien WE,Clark GD, et al.3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. J Inherit Metab Dis, 2003, 26(1): 69-71.
[6]	Sass JO,Forstner R,Sperl W. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency：impaired catabolism of isoleucine presenting as neurodegenerative disease[J]. Brain Dev, 2004, 26(1): 12-14.
[7]	Poll-The BT,Wanders RJ,Ruiter JP, et al.Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases[J]. Mol Genet Metab, 2004, 81(4): 295-299.
[8]	Perez-Cerda C,Garcia-Villoria J,Ofman R, et al.2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency：an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease[J]. Pediatr Res, 2005, 58(3): 488-491.
[9]	Cazorla MR,Verdu A,Perez-Cerda C, et al.Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Pediatr Neurol, 2007, 36(4): 264-267.
[10]	Lenski C,Kooy RF,Reyniers E, et al.The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior[J]. Am J Hum Genet, 2007, 80(2): 372-377.
[11]	Garcia-Villoria J,Navarro-Sastre A,Fons C, et al.Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoAdehydrogenase(MHBD) deficiency：difficulties in the diagnosis[J]. Clin Biochem, 2009, 42(1-2): 27-33.
[12]	Rauschenberger K,Schöler K,Sass JO, et al.A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival[J]. EMBO Mol Med, 2010, 2(2): 51-62.
[13]	Seaver LH,He XY,Abe K, et al.A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability[J]. PLoS One, 2011, 6(11), e27348.
[14]	舒剑波,张玉琴,姜淑贞, 等.2甲基3羟基丁酰辅酶A脱氢酶缺陷症一家系基因突变分析[J]. 中华儿科杂志, 2013, 51(10): 783-786.
[15]	Fukao T,Akiba K,Goto M , et al.The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation.Journal of Human Genetics[J]. J Hum Genet, 2014, 59(9): 521-528.
[16]	满宜刚,盛志强. 婴儿痉挛征患儿智能结构变化对综合康复训练效果的判断价值[J/CD]. 中华诊断学电子杂志, 2014, 2(4): 298-300.
[17]	Korman SH,Yang SY.HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Mol Genet Metab, 2007, 91(1): 115.
[18]	He XY,Merz G,Yang YZ, et al.Characterization and localization of human type10 17beta hydroxysteroid dehydrogenase[J]. Eur J Biochem, 2001, 268(18): 4899-4907.
[19]	Yang SY,He XY,Isaacs C, et al.Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders[J]. J Steroid Biochem Mol Biol, 2014, 143: 460-472.

Please choose a citation manager

Content to export